Screener
Veradermics MANE Interest Income
Interest Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Veradermics in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The source filing: Veradermics’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 5:06 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001827635-26-000019
| (in thousands, except share and per share amounts) | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Total operating expenses | 29,862 | 12,915 |
| Loss from operations | (29,862) | (12,915) |
| Other income: | ||
| Interest income | 2,481 | 482 |
| Other income | 149 | 33 |
| Total other income, net | 2,630 | 515 |
| Loss before income taxes | (27,232) | (12,400) |
| Income tax benefit | — | — |
Item 1. Condensed Consolidated Financial Statements (
FAQ
- What is Veradermics's interest income?
- Veradermics (MANE) reported interest income of $2.48M in Q1 2026.
- How has Veradermics's interest income changed year-over-year?
- Veradermics's interest income increased by 414.7% year-over-year, from $482K to $2.48M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.
Ask your AI about Veradermics's interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude